AZD5363 is an orally active, selective protein kinase B (PKB, also known as Akt) inhibitor

1: Davies BR, Greenwood H, Dudley P, Crafter C, Yu DH, Zhang J, Li J, Gao B, Ji Q, Maynard J, Ricketts SA, Cross D, Cosulich SC, Chresta CM, Page K, Yates J, Lane C, Watson R, Luke R, Ogilvie DJ, Pass M. Preclinical Pharmacology of AZD5363, an Orally Bioavailable Inhibitor of AKT: Pharmacodynamics, Antitumor Activity and Correlation of Monotherapy Activity with Genetic Background. Mol Cancer Ther. 2012 Jan 31. [Epub ahead of print] PubMed PMID: 22294718.